CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Patient Input and Clinical Experts: etonogestrel

Published on: May 6, 2020
Result type: News

CADTH has received the following notice(s) of pending drug submission(s).

Brand name TBC
Generic name etonogestrel
Manufacturer Merck Canada Inc.
Indication(s) Prevention of pregnancy
Project Number SR0648-000
Call for patient input 2020-05-06
Patient input deadline 2020-06-25
Submit patient input Submit
Register as Clinical Expert Register